Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,426 articles

Articles by Daniel Marsh

Cipher Digital Stock Surges on AI Data Center Expansion Plans
Markets

Cipher Digital Stock Surges on AI Data Center Expansion Plans

Cipher Digital shares surged 9.5% to $25.21, approaching a 52-week high, as the company announced new AI data center leases and a $200 million credit facility.

CIFR
Tesla Shares Rise on European Sales Rebound, BYD Maintains Lead
Markets

Tesla Shares Rise on European Sales Rebound, BYD Maintains Lead

Tesla shares climbed 1.4% to $439.61 after European registrations jumped 46.5% in April. BYD outpaced Tesla with a 114.5% surge, remaining the top EV seller in Europe.

TSLA
Grab Shares Climb as Superbank Consolidation Nears
Markets

Grab Shares Climb as Superbank Consolidation Nears

Grab Holdings shares rose 1.3% Wednesday after announcing the consolidation of Indonesia's Superbank into its financial services segment, with financial services revenue up 43% to $107 million.

GRAB UBER
Keel Infrastructure Surges as AI Data Center Play Gains Traction
Markets

Keel Infrastructure Surges as AI Data Center Play Gains Traction

Keel Infrastructure shares rose 7.99% to $5.54 on heavy volume, driven by investor interest in its AI infrastructure pivot, though Q1 revenue fell 23%.

IREN
Intuitive Surgical Dips on Goldman Sachs Price Target Cut Amid Medtech Weakness
Markets

Intuitive Surgical Dips on Goldman Sachs Price Target Cut Amid Medtech Weakness

Intuitive Surgical shares slid over 4% after Goldman Sachs cut its price target to $558. The medtech giant posted strong Q1 revenue growth but faces tariff and competitive headwinds.

ISRG MDT SYK SPY
Archer Aviation Shares Dip Amid Cash Burn Concerns and FAA Progress
Markets

Archer Aviation Shares Dip Amid Cash Burn Concerns and FAA Progress

Archer Aviation shares slipped to $6.49 after reporting a Q1 net loss of $217.7M. The company completed Phase 3 of FAA type certification for its eVTOL aircraft, but ongoing cash burn pressures persist.

ACHR JOBY EVEX
Opendoor Stock Jumps on Russell 3000 Index Inclusion
Markets

Opendoor Stock Jumps on Russell 3000 Index Inclusion

Opendoor Technologies shares rose 8.6% on news of its upcoming inclusion in the Russell 3000 Index, with over 36 million shares traded.

OPEN Z ZG
IREN Stock Surges on $1.6B Dell Deal to Accelerate AI Infrastructure
Markets

IREN Stock Surges on $1.6B Dell Deal to Accelerate AI Infrastructure

IREN shares rose 9.4% to $65.42 after announcing a $1.6 billion Dell hardware deal to speed up Nvidia Blackwell system deployment, with a $4.4 billion annualized revenue target.

IREN DELL NVDA
NIO Shares Surge on ES9 SUV Debut with Yao Ming; Delivery Targets in Focus
Markets

NIO Shares Surge on ES9 SUV Debut with Yao Ming; Delivery Targets in Focus

NIO shares jumped 8.6% to $5.71 after unveiling the ES9 SUV with Yao Ming as brand ambassador. The company targets Q2 deliveries of 110,000-115,000 vehicles.

NIO LI XPEV BABA FXI
Astrotech Surges 524% on Moon Mining Plan Despite No NASA Role
Markets

Astrotech Surges 524% on Moon Mining Plan Despite No NASA Role

Astrotech shares soared 524% on lunar mining and quantum plans, but the company lacks NASA contracts and reported a $3.8 million quarterly loss.

ASTC
Verra Mobility Tumbles 71% as Avis Budget Ends Contract
Analysis

Verra Mobility Tumbles 71% as Avis Budget Ends Contract

Verra Mobility shares fell 71.4% after Avis Budget said it will end its contract in September 2026, cutting a key revenue source and prompting analyst downgrades.

VRM CAR HTZ
Boston Scientific Plunges to Two-Year Low on Watchman Slowdown
Markets

Boston Scientific Plunges to Two-Year Low on Watchman Slowdown

Boston Scientific shares fell 10% to a two-year low after CEO Michael Mahoney flagged slower use of its Watchman heart implant, raising growth concerns.

BSX MDT JNJ ABT